Kymera Therapeutics amends bylaws to require federal courts for securities lawsuits

Filed March 27, 2026 · Period ending March 25, 2026 · ~1 min read

Key Changes

• low

  Board amended bylaws to designate federal district courts as exclusive forum for Securities Act and Exchange Act claims, unless company consents to alternative venue in writing.

  Item 5.03 verify on EDGAR →
• low

  Change is procedural governance update responding to recent Delaware corporate law amendments, limiting where shareholders can file certain securities litigation.

  8-K: Bylaw Amendment verify on EDGAR →